Sector portfolio · VC firm · United States

Atlas Venture's Biotech portfolio

Atlas Venture has backed 47 Biotech startups in rounds we track, $5.5B between them, shown by the stage each has reached. The best-funded is Dyne Therapeutics.

47startups backed
5stages
$5.5Braised between them
Series Abiggest stage

Atlas Venture's whole portfolioAtlas Venture's profile

Series A

20

Series B

12

Series C and later

7

Stage not reported

6

Pre-seed and seed

2

Segment by segment

Series A

20 startups · $2.2B raised

  1. Dyne TherapeuticsDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.United States$828M
  2. Disc MedicineDisc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.United States$275M
  3. Ethyreal BioEthyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.United States$161M
  4. GTGemini TherapeuticsGemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.United States$138M
  5. Trace NeuroscienceLaunched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for peoUnited States$101M
  6. VTVima TherapeuticsUnited States$100M
  7. AvrobioAvrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.United States$85M
  8. IFM TherapeuticsIFM Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, focused on developing innovative therapies for canUnited States$83M

Series B

12 startups · $2.1B raised

  1. Kailera TherapeuticsKailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.United States$600M
  2. Intellia TherapeuticsIntellia Therapeutics is a genome editing company that develops curative gene-editing treatments.United States$485M
  3. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  4. Mariana OncologyMariana Oncology is a biotechnology research industry.United States$175M
  5. Vigil NeuroscienceVigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.United States$130M
  6. Pheon TherapeuticsPheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treatUnited Kingdom$120M
  7. Bicycle TherapeuticsBicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.United Kingdom$110M
  8. RReplimuneUnited Kingdom$85M

Series C and later

7 startups · $840M raised

  1. Spero TherapeuticsSpero Therapeutics develops therapeutics for treatment of gram-negative infections.United States$199M
  2. Magenta TherapeuticsMagenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.United States$187M
  3. Sionna TherapeuticsSionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).United States$182M
  4. Triveni BioTriveni Bio is a clinical-stage biotechnology company based in Watertown, Massachusetts, founded in 2019 through the merger of AmaUnited States$180M
  5. Rodin TherapeuticsRodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.United States$40M
  6. Momenta PharmaceuticalsMomenta Pharmaceuticals, Inc.United States$40M
  7. PPercardiaPercardia is a medical device company that develops therapies for the treatment of coronary artery disease.United States$13M

Stage not reported

6 startups · $191M raised

  1. Remix TherapeuticsRemix Therapeutics is a biotechnology company that is working on developing small molecule medicines.United States$60M
  2. Ikena OncologyIkena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.United States$40M
  3. Avila TherapeuticsAvila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.United States$32M
  4. ATArteaus TherapeuticsArteaus Therapeutics is a biotechnology development company focused on creating new therapies to treat migraine.United States$30M
  5. RPResolvyx PharmaceuticalsResolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.United States$21M
  6. Indalo TherapeuticsIndalo Therapeutics, Inc.United States$9.0M

Pre-seed and seed

2 startups · $155M raised

  1. Nvelop TherapeuticsNvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.United States$100M
  2. Renasant BioRenasant Bio is a biopharmaceutical company based in Berkeley, California, focused on developing oral small molecule therapies forUnited States$55M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Atlas Venture as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioAtlas Venture's IT Services portfolio18 startups · $337MCo-investorsWho invests with Atlas Venture177 co-investorsPortfolio mapAtlas Venture portfolio map132 startups · $11BSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426B

Raising from investors like Atlas Venture?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps